Seeking Alpha

MedGuy103

MedGuy103
Send Message
View as an RSS Feed
View MedGuy103's Comments BY TICKER:
Latest  |  Highest rated
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    That's great Al, er... Betty. Anyway, I'll be tuned in.
    Mar 2, 2015. 12:35 PM | Likes Like |Link to Comment
  • MEI Pharma: A Rare Hidden Gem With Impressive Clinical Data [View article]
    Good thing I don't particularly like oysters!
    Mar 1, 2015. 04:55 PM | Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    You're glancing over the obvious. The trend is because there were likely survivors at the study's end with short TLs. "Exploratory analysis demonstrated a trend toward longer median PFS (HR = 0.43; 95% CI 0.14-1.3; P = 0.124) and overall survival (OS; HR = 0.41; 95% CI 0.11-1.46; P = 0.155) in imetelstat-treated patients with short TL" Believe what you want. The facts were clearly towards strong results for short TL. Sometime this year or next we'll likely hear about a study specifically looking at solid tumors screened for short TL biomarker. When that happens, jaws will drop.
    Mar 1, 2015. 03:53 PM | 3 Likes Like |Link to Comment
  • The Natural Gas Rebound Will Be Fueled By Low Oil Prices [View article]
    If any banks were invested in oil/gas derivatives of course there would be writeoffs; the probablility that many single derivative investments have gone to $0 is highly likely.
    Mar 1, 2015. 01:11 PM | Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    Yeah what Lev said
    Mar 1, 2015. 12:30 PM | 1 Like Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    I think what you're missing is the following. Whereas the study failed its endpoints in the entire population (though did show a trend of positive improvement), it did show clear evidence of improvement in the short telomere population. If, in fact, the short telomere was a relative small portion of the patients, you can deduce that the improvement in PFS statistically could be very significant. I would argue that it looks highly probable from what was presented, which is why the the last sentence in the conclusion suggest further study with patients with short TL. This is further evidence of Imet's efficacy in patients with short TL biomarker.
    Mar 1, 2015. 12:28 PM | Likes Like |Link to Comment
  • MEI Pharma: A Rare Hidden Gem With Impressive Clinical Data [View article]
    Have a sense of humor, it good for your health
    Mar 1, 2015. 02:38 AM | Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    This may have already been posted, so apologies if it already was. Still, it demonstrates that there are other Imetelstat trials going on beyond what JNJ is working on with Geron. This Phase II shows promise for Advanced NSCLC with short TL: http://1.usa.gov/1CaxPDD
    So once again, I must say, there is no reason to sell GERN now. Good news may come in many different forms and originating from any number of trials.
    Feb 28, 2015. 06:50 PM | 3 Likes Like |Link to Comment
  • MEI Pharma: A Rare Hidden Gem With Impressive Clinical Data [View article]
    Yes sometimes a new moniker is needed when the old moniker decides not to dry clean her dress.
    Feb 28, 2015. 06:17 PM | Likes Like |Link to Comment
  • MEI Pharma: A Rare Hidden Gem With Impressive Clinical Data [View article]
    Do I need to get the unscrolled scroll out again?
    Feb 28, 2015. 02:36 PM | Likes Like |Link to Comment
  • The Natural Gas Rebound Will Be Fueled By Low Oil Prices [View article]
    Thanks for repeating what I said.
    Feb 27, 2015. 10:32 PM | Likes Like |Link to Comment
  • Why I'm Long SodaStream [View article]
    Guess I wuz right
    Feb 27, 2015. 10:28 PM | 3 Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    My favorite Warren Buffett quote: " The stock market is a device for transferring money from the impatient to the patient." Lesson: Don't sell GERN, too much good news on the horizon.
    Feb 27, 2015. 04:58 PM | 6 Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    I was referring to short funds
    Feb 27, 2015. 04:42 PM | Likes Like |Link to Comment
  • Dr. Sergei Gryaznov: Geron Should Develop Imetelstat For ET/PV [View article]
    That tells me hedgies are jonesing to get it under $3. Not surprised.
    Feb 27, 2015. 02:55 PM | Likes Like |Link to Comment
COMMENTS STATS
1,117 Comments
1,216 Likes